Ipidacrine (also known as Amiridine, NIK-247, CAS 62732-44-9) is a potent cholinesterase inhibitor and nootropic agent with significant therapeutic potential in the treatment of Alzheimer’s disease and other cognitive disorders . As a reversible inhibitor of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), with IC50 values of approximately 1 μM and 1.9 μM respectively, it also functions as a partial agonist at M2-cholinergic receptors and stimulates neuromuscular transmission . Available in multiple forms including free base, hydrochloride salt, and hydrochloride monohydrate, ipidacrine serves both the pharmaceutical research and finished pharmaceutical product markets . Understanding the global buyers list is essential for API suppliers, research chemical distributors, and manufacturers seeking to expand their reach in…